Letter from the Editor

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Letter from the Editor


Try not to become a man of success but a man of value. — Albert Einstein. Einstein might have been describing this year’s ­Pharma­VOICE 100 honorees. This distinguished group of individuals — men and women — are committed to achieving results that lead to the greater good for their colleagues, their companies, the patients they serve, and their fellow (wo)man. Every year, we have the distinct honor of showcasing 100 extraordinary leaders, many of them unsung heroes who sit outside the C-suite, although we have plenty of these too. And it is only because of you, our readers, that we have the opportunity to share them with you. This special publication, now in its eighth year, is truly the feel-good issue of the year and one of the most anticipated. Each year the list of honorees is more diverse and eclectic, which is a reflection of the changing life-sciences landscape and the scope of our readership and reach. (We even received a nomination from a Hollywood A-lister.) Over the past several months, we have had the privilege to get to know this year’s PharmaVOICE 100. And I want to thank each of them for taking the time to share their very personal stories with us, which we can now share with you. They certainly demonstrate how passion, integrity, and innovative thinking can move the needle to positively impact health and wellness for millions. To make the issue easy to navigate, we have divided the honorees into categories that we believe best capture their expertise, which is no easy task as each could easily fit into several of the following sections: commanders and chiefs, entrepreneurs, change agents, clinical specialists, researchers and scientists, marketers, creatives, patient advocates, technologists, and mentors. Please join us in extending warm congratulations to this year’s PharmaVOICE 100. Don’t forget to check out the exclusive bonus content found only in our digital edition, which can be accessed via the QR code at the end of each profile, or via our website at pharma­voice.com, just click on the PharmaVOICE 100 cover image. We can’t wait to see who makes next year’s list. Submit your nominations for 2013 now. Their Word… Denise Myshko Managing Editor This year’s PV 100 honorees are true ­leaders in the industry; they are admired by their peers as they work tirelessly to address the challenges facing the ­industry. Robin Robinson Senior Editor From the scientists to the marketers, from the ­entrepreneurs to the mentors, and all of the other fascinating leaders ­represented in our PV 100 issue, the one common ­denominator is their singular dedication to ­improving the world around them. Kim Ribbink Features Editor The impact great l­­­­eaders and mentors have on those they ­interact with stands out in this year’s ­PharmaVOICE 100; it’s apparent that what they give back is far more important than their ­individual achievements. The forum for the industry executive Volume 12 • Number 7 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account managerS Trish Kane Cathy Tracy WEBCAST?NETWORK?PRODUCER Daniel Limbach CIRCULATION Assistant Kathy Deiuliis Copyright 2012 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Twelve, Number Seven PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by ­Pharma­­Linx LLC, P.O.?Box 327, Titusville, NJ 08560. ­Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices. Postmaster: Send address changes to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. PharmaVoice Coverage and Distribution: Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O.?Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197. Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com. Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: mwalsh@pharmavoice.com. Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change. Advertising in PharmaVoice: To advertise in Pharma­­Voice please contact our Advertising ­Department at P.O.?Box 327, Titusville, NJ 08560, or ­telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com. Coming in September > Behavioral Marketing > E-Patients > Diagnostics > Sunshine Act > Global Product Registration > Emerging Market — India > C-Suite — Pharmaceutical Companies > Showcase Features — Data Management Marketing Letters Send your letters to feedback@pharma­voice.com. Please include your name, title, company, and business phone number. Letters chosen for publication may be edited for length and clarity. All submissions become the property of PharmaLinx LLEU.

Posted in:

Post a Comment

You must be logged in to post a Comment.